The Food and Drug Administration issued a safety advisory on Haemonetics’ Leukotrap RC System, warning that faulty filters in some of the recently distributed devices can result in high leukocyte ...
The firm originally filed a BLA in 2023, but the FDA twice delayed its approval decision on the gene therapy and requested more CMC information.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback